img

Global Bile Duct Cancer Drug Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 282 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bile Duct Cancer Drug Sales Market Report 2024

The global Bile Duct Cancer Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bile Duct Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Cabozantinib S-malate
Elpamotide
Exatecan Mesylate
LY-2801653
NUC-1031
Others


Segment by Application


Hospital
Clinic
Others

The Bile Duct Cancer Drug market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Bile Duct Cancer Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Ariad Pharmaceuticals, Inc.
ArQule, Inc.
Array BioPharma Inc.
Arrien Pharmaceuticals, LLC
Aslan Pharmaceuticals Pte. Ltd.
Bavarian Nordic A/S
Bayer AG
Blueprint Medicines Corporation
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
CellAct Pharma GmbH
Cellceutix Corporation
Cellular Biomedicine Group, Inc.
Concordia Healthcare Corp.

Table of Content

1 Bile Duct Cancer Drug Market Overview
1.1 Bile Duct Cancer Drug Product Scope
1.2 Bile Duct Cancer Drug Segment by Type
1.2.1 Global Bile Duct Cancer Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Cabozantinib S-malate
1.2.3 Elpamotide
1.2.4 Exatecan Mesylate
1.2.5 LY-2801653
1.2.6 NUC-1031
1.2.7 Others
1.3 Bile Duct Cancer Drug Segment by Application
1.3.1 Global Bile Duct Cancer Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Bile Duct Cancer Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Bile Duct Cancer Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Bile Duct Cancer Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Bile Duct Cancer Drug Price Trends (2016-2027)

2 Bile Duct Cancer Drug Estimates and Forecasts by Region
2.1 Global Bile Duct Cancer Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Bile Duct Cancer Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Bile Duct Cancer Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Bile Duct Cancer Drug Revenue Market Share by Region (2016-2021)
2.3 Global Bile Duct Cancer Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Bile Duct Cancer Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Bile Duct Cancer Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Bile Duct Cancer Drug Estimates and Projections (2016-2027)
2.4.2 Europe Bile Duct Cancer Drug Estimates and Projections (2016-2027)
2.4.3 China Bile Duct Cancer Drug Estimates and Projections (2016-2027)
2.4.4 Japan Bile Duct Cancer Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Bile Duct Cancer Drug Estimates and Projections (2016-2027)
2.4.6 India Bile Duct Cancer Drug Estimates and Projections (2016-2027)

3 Global Bile Duct Cancer Drug Competition Landscape by Players
3.1 Global Top Bile Duct Cancer Drug Players by Sales (2016-2021)
3.2 Global Top Bile Duct Cancer Drug Players by Revenue (2016-2021)
3.3 Global Bile Duct Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bile Duct Cancer Drug as of 2020)
3.4 Global Bile Duct Cancer Drug Average Price by Company (2016-2021)
3.5 Manufacturers Bile Duct Cancer Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Bile Duct Cancer Drug Market Size by Type
4.1 Global Bile Duct Cancer Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Bile Duct Cancer Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Bile Duct Cancer Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Bile Duct Cancer Drug Price by Type (2016-2021)
4.2 Global Bile Duct Cancer Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Bile Duct Cancer Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Bile Duct Cancer Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Bile Duct Cancer Drug Price Forecast by Type (2022-2027)

5 Global Bile Duct Cancer Drug Market Size by Application
5.1 Global Bile Duct Cancer Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Bile Duct Cancer Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Bile Duct Cancer Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Bile Duct Cancer Drug Price by Application (2016-2021)
5.2 Global Bile Duct Cancer Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Bile Duct Cancer Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Bile Duct Cancer Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Bile Duct Cancer Drug Price Forecast by Application (2022-2027)

6 North America Bile Duct Cancer Drug Market Facts & Figures
6.1 North America Bile Duct Cancer Drug Sales by Company
6.1.1 North America Bile Duct Cancer Drug Sales by Company (2016-2021)
6.1.2 North America Bile Duct Cancer Drug Revenue by Company (2016-2021)
6.2 North America Bile Duct Cancer Drug Sales Breakdown by Type
6.2.1 North America Bile Duct Cancer Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Bile Duct Cancer Drug Sales Breakdown by Type (2022-2027)
6.3 North America Bile Duct Cancer Drug Sales Breakdown by Application
6.3.1 North America Bile Duct Cancer Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Bile Duct Cancer Drug Sales Breakdown by Application (2022-2027)

7 Europe Bile Duct Cancer Drug Market Facts & Figures
7.1 Europe Bile Duct Cancer Drug Sales by Company
7.1.1 Europe Bile Duct Cancer Drug Sales by Company (2016-2021)
7.1.2 Europe Bile Duct Cancer Drug Revenue by Company (2016-2021)
7.2 Europe Bile Duct Cancer Drug Sales Breakdown by Type
7.2.1 Europe Bile Duct Cancer Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Bile Duct Cancer Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Bile Duct Cancer Drug Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Bile Duct Cancer Drug Market Facts & Figures
8.1 China Bile Duct Cancer Drug Sales by Company
8.1.1 China Bile Duct Cancer Drug Sales by Company (2016-2021)
8.1.2 China Bile Duct Cancer Drug Revenue by Company (2016-2021)
8.2 China Bile Duct Cancer Drug Sales Breakdown by Type
8.2.1 China Bile Duct Cancer Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Bile Duct Cancer Drug Sales Breakdown by Type (2022-2027)
8.3 China Bile Duct Cancer Drug Sales Breakdown by Application
8.3.1 China 166 Sales Breakdown by Application (2016-2021)
8.3.2 China 166 Sales Breakdown by Application (2022-2027)

9 Japan Bile Duct Cancer Drug Market Facts & Figures
9.1 Japan Bile Duct Cancer Drug Sales by Company
9.1.1 Japan Bile Duct Cancer Drug Sales by Company (2016-2021)
9.1.2 Japan Bile Duct Cancer Drug Revenue by Company (2016-2021)
9.2 Japan Bile Duct Cancer Drug Sales Breakdown by Type
9.2.1 Japan Bile Duct Cancer Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Bile Duct Cancer Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Bile Duct Cancer Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Bile Duct Cancer Drug Market Facts & Figures
10.1 Southeast Asia Bile Duct Cancer Drug Sales by Company
10.1.1 Southeast Asia Bile Duct Cancer Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Bile Duct Cancer Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Bile Duct Cancer Drug Sales Breakdown by Type
10.2.1 Southeast Asia Bile Duct Cancer Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Bile Duct Cancer Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Bile Duct Cancer Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Bile Duct Cancer Drug Market Facts & Figures
11.1 India Bile Duct Cancer Drug Sales by Company
11.1.1 India Bile Duct Cancer Drug Sales by Company (2016-2021)
11.1.2 India Bile Duct Cancer Drug Revenue by Company (2016-2021)
11.2 India Bile Duct Cancer Drug Sales Breakdown by Type
11.2.1 India Bile Duct Cancer Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Bile Duct Cancer Drug Sales Breakdown by Type (2022-2027)
11.3 India Bile Duct Cancer Drug Sales Breakdown by Application
11.3.1 India Bile Duct Cancer Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Bile Duct Cancer Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Bile Duct Cancer Drug Business
12.1 Ariad Pharmaceuticals, Inc.
12.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
12.1.2 Ariad Pharmaceuticals, Inc. Business Overview
12.1.3 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Products Offered
12.1.5 Ariad Pharmaceuticals, Inc. Recent Development
12.2 ArQule, Inc.
12.2.1 ArQule, Inc. Corporation Information
12.2.2 ArQule, Inc. Business Overview
12.2.3 ArQule, Inc. Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 ArQule, Inc. Bile Duct Cancer Drug Products Offered
12.2.5 ArQule, Inc. Recent Development
12.3 Array BioPharma Inc.
12.3.1 Array BioPharma Inc. Corporation Information
12.3.2 Array BioPharma Inc. Business Overview
12.3.3 Array BioPharma Inc. Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Array BioPharma Inc. Bile Duct Cancer Drug Products Offered
12.3.5 Array BioPharma Inc. Recent Development
12.4 Arrien Pharmaceuticals, LLC
12.4.1 Arrien Pharmaceuticals, LLC Corporation Information
12.4.2 Arrien Pharmaceuticals, LLC Business Overview
12.4.3 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Products Offered
12.4.5 Arrien Pharmaceuticals, LLC Recent Development
12.5 Aslan Pharmaceuticals Pte. Ltd.
12.5.1 Aslan Pharmaceuticals Pte. Ltd. Corporation Information
12.5.2 Aslan Pharmaceuticals Pte. Ltd. Business Overview
12.5.3 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Products Offered
12.5.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
12.6 Bavarian Nordic A/S
12.6.1 Bavarian Nordic A/S Corporation Information
12.6.2 Bavarian Nordic A/S Business Overview
12.6.3 Bavarian Nordic A/S Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bavarian Nordic A/S Bile Duct Cancer Drug Products Offered
12.6.5 Bavarian Nordic A/S Recent Development
12.7 Bayer AG
12.7.1 Bayer AG Corporation Information
12.7.2 Bayer AG Business Overview
12.7.3 Bayer AG Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bayer AG Bile Duct Cancer Drug Products Offered
12.7.5 Bayer AG Recent Development
12.8 Blueprint Medicines Corporation
12.8.1 Blueprint Medicines Corporation Corporation Information
12.8.2 Blueprint Medicines Corporation Business Overview
12.8.3 Blueprint Medicines Corporation Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Blueprint Medicines Corporation Bile Duct Cancer Drug Products Offered
12.8.5 Blueprint Medicines Corporation Recent Development
12.9 Boehringer Ingelheim GmbH
12.9.1 Boehringer Ingelheim GmbH Corporation Information
12.9.2 Boehringer Ingelheim GmbH Business Overview
12.9.3 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Products Offered
12.9.5 Boehringer Ingelheim GmbH Recent Development
12.10 Boston Biomedical, Inc.
12.10.1 Boston Biomedical, Inc. Corporation Information
12.10.2 Boston Biomedical, Inc. Business Overview
12.10.3 Boston Biomedical, Inc. Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Boston Biomedical, Inc. Bile Duct Cancer Drug Products Offered
12.10.5 Boston Biomedical, Inc. Recent Development
12.11 Bristol-Myers Squibb Company
12.11.1 Bristol-Myers Squibb Company Corporation Information
12.11.2 Bristol-Myers Squibb Company Business Overview
12.11.3 Bristol-Myers Squibb Company Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bristol-Myers Squibb Company Bile Duct Cancer Drug Products Offered
12.11.5 Bristol-Myers Squibb Company Recent Development
12.12 Celgene Corporation
12.12.1 Celgene Corporation Corporation Information
12.12.2 Celgene Corporation Business Overview
12.12.3 Celgene Corporation Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Celgene Corporation Bile Duct Cancer Drug Products Offered
12.12.5 Celgene Corporation Recent Development
12.13 CellAct Pharma GmbH
12.13.1 CellAct Pharma GmbH Corporation Information
12.13.2 CellAct Pharma GmbH Business Overview
12.13.3 CellAct Pharma GmbH Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 CellAct Pharma GmbH Bile Duct Cancer Drug Products Offered
12.13.5 CellAct Pharma GmbH Recent Development
12.14 Cellceutix Corporation
12.14.1 Cellceutix Corporation Corporation Information
12.14.2 Cellceutix Corporation Business Overview
12.14.3 Cellceutix Corporation Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cellceutix Corporation Bile Duct Cancer Drug Products Offered
12.14.5 Cellceutix Corporation Recent Development
12.15 Cellular Biomedicine Group, Inc.
12.15.1 Cellular Biomedicine Group, Inc. Corporation Information
12.15.2 Cellular Biomedicine Group, Inc. Business Overview
12.15.3 Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Products Offered
12.15.5 Cellular Biomedicine Group, Inc. Recent Development
12.16 Concordia Healthcare Corp.
12.16.1 Concordia Healthcare Corp. Corporation Information
12.16.2 Concordia Healthcare Corp. Business Overview
12.16.3 Concordia Healthcare Corp. Bile Duct Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Concordia Healthcare Corp. Bile Duct Cancer Drug Products Offered
12.16.5 Concordia Healthcare Corp. Recent Development

13 Bile Duct Cancer Drug Manufacturing Cost Analysis
13.1 Bile Duct Cancer Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bile Duct Cancer Drug
13.4 Bile Duct Cancer Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bile Duct Cancer Drug Distributors List
14.3 Bile Duct Cancer Drug Customers

15 Market Dynamics
15.1 Bile Duct Cancer Drug Market Trends
15.2 Bile Duct Cancer Drug Drivers
15.3 Bile Duct Cancer Drug Market Challenges
15.4 Bile Duct Cancer Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Bile Duct Cancer Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Bile Duct Cancer Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Bile Duct Cancer Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Bile Duct Cancer Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Bile Duct Cancer Drug Sales Market Share by Region (2016-2021)
Table 6. Global Bile Duct Cancer Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Bile Duct Cancer Drug Revenue Share by Region (2016-2021)
Table 8. Global Bile Duct Cancer Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Bile Duct Cancer Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Bile Duct Cancer Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Bile Duct Cancer Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Bile Duct Cancer Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Bile Duct Cancer Drug Sales Share by Company (2016-2021)
Table 14. Global Bile Duct Cancer Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Bile Duct Cancer Drug Revenue Share by Company (2016-2021)
Table 16. Global Bile Duct Cancer Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer Drug as of 2020)
Table 17. Global Bile Duct Cancer Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Bile Duct Cancer Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Bile Duct Cancer Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Bile Duct Cancer Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Bile Duct Cancer Drug Sales Share by Type (2016-2021)
Table 23. Global Bile Duct Cancer Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Bile Duct Cancer Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Bile Duct Cancer Drug Sales Share by Type (2022-2027)
Table 26. Global Bile Duct Cancer Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Bile Duct Cancer Drug Revenue Share by Type (2022-2027)
Table 28. Global Bile Duct Cancer Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Bile Duct Cancer Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Bile Duct Cancer Drug Sales Share by Application (2016-2021)
Table 31. Global Bile Duct Cancer Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Bile Duct Cancer Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Bile Duct Cancer Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Bile Duct Cancer Drug Sales Share by Application (2022-2027)
Table 35. Global Bile Duct Cancer Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Bile Duct Cancer Drug Revenue Share by Application (2022-2027)
Table 37. Global Bile Duct Cancer Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Bile Duct Cancer Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Bile Duct Cancer Drug Sales Market Share by Company (2016-2021)
Table 40. North America Bile Duct Cancer Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Bile Duct Cancer Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Bile Duct Cancer Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Bile Duct Cancer Drug Sales Market Share by Type (2016-2021)
Table 44. North America Bile Duct Cancer Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Bile Duct Cancer Drug Sales Market Share by Type (2022-2027)
Table 46. North America Bile Duct Cancer Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Bile Duct Cancer Drug Sales Market Share by Application (2016-2021)
Table 48. North America Bile Duct Cancer Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Bile Duct Cancer Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Bile Duct Cancer Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Bile Duct Cancer Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Bile Duct Cancer Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Bile Duct Cancer Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Bile Duct Cancer Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Bile Duct Cancer Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Bile Duct Cancer Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Bile Duct Cancer Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Bile Duct Cancer Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Bile Duct Cancer Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Bile Duct Cancer Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Bile Duct Cancer Drug Sales Market Share by Application (2022-2027)
Table 62. China Bile Duct Cancer Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Bile Duct Cancer Drug Sales Market Share by Company (2016-2021)
Table 64. China Bile Duct Cancer Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Bile Duct Cancer Drug Revenue Market Share by Company (2016-2021)
Table 66. China Bile Duct Cancer Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Bile Duct Cancer Drug Sales Market Share by Type (2016-2021)
Table 68. China Bile Duct Cancer Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Bile Duct Cancer Drug Sales Market Share by Type (2022-2027)
Table 70. China Bile Duct Cancer Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Bile Duct Cancer Drug Sales Market Share by Application (2016-2021)
Table 72. China Bile Duct Cancer Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Bile Duct Cancer Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Bile Duct Cancer Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Bile Duct Cancer Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Bile Duct Cancer Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Bile Duct Cancer Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Bile Duct Cancer Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Bile Duct Cancer Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Bile Duct Cancer Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Bile Duct Cancer Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Bile Duct Cancer Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Bile Duct Cancer Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Bile Duct Cancer Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Bile Duct Cancer Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Bile Duct Cancer Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Bile Duct Cancer Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Bile Duct Cancer Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Bile Duct Cancer Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Bile Duct Cancer Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Bile Duct Cancer Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Bile Duct Cancer Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Bile Duct Cancer Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Bile Duct Cancer Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Bile Duct Cancer Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Bile Duct Cancer Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Bile Duct Cancer Drug Sales Market Share by Application (2022-2027)
Table 98. India Bile Duct Cancer Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Bile Duct Cancer Drug Sales Market Share by Company (2016-2021)
Table 100. India Bile Duct Cancer Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Bile Duct Cancer Drug Revenue Market Share by Company (2016-2021)
Table 102. India Bile Duct Cancer Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Bile Duct Cancer Drug Sales Market Share by Type (2016-2021)
Table 104. India Bile Duct Cancer Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Bile Duct Cancer Drug Sales Market Share by Type (2022-2027)
Table 106. India Bile Duct Cancer Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Bile Duct Cancer Drug Sales Market Share by Application (2016-2021)
Table 108. India Bile Duct Cancer Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Bile Duct Cancer Drug Sales Market Share by Application (2022-2027)
Table 110. Ariad Pharmaceuticals, Inc. Corporation Information
Table 111. Ariad Pharmaceuticals, Inc. Description and Business Overview
Table 112. Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Product
Table 114. Ariad Pharmaceuticals, Inc. Recent Development
Table 115. ArQule, Inc. Corporation Information
Table 116. ArQule, Inc. Description and Business Overview
Table 117. ArQule, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. ArQule, Inc. Bile Duct Cancer Drug Product
Table 119. ArQule, Inc. Recent Development
Table 120. Array BioPharma Inc. Corporation Information
Table 121. Array BioPharma Inc. Description and Business Overview
Table 122. Array BioPharma Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Array BioPharma Inc. Bile Duct Cancer Drug Product
Table 124. Array BioPharma Inc. Recent Development
Table 125. Arrien Pharmaceuticals, LLC Corporation Information
Table 126. Arrien Pharmaceuticals, LLC Description and Business Overview
Table 127. Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Product
Table 129. Arrien Pharmaceuticals, LLC Recent Development
Table 130. Aslan Pharmaceuticals Pte. Ltd. Corporation Information
Table 131. Aslan Pharmaceuticals Pte. Ltd. Description and Business Overview
Table 132. Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Product
Table 134. Aslan Pharmaceuticals Pte. Ltd. Recent Development
Table 135. Bavarian Nordic A/S Corporation Information
Table 136. Bavarian Nordic A/S Description and Business Overview
Table 137. Bavarian Nordic A/S Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Bavarian Nordic A/S Bile Duct Cancer Drug Product
Table 139. Bavarian Nordic A/S Recent Development
Table 140. Bayer AG Corporation Information
Table 141. Bayer AG Description and Business Overview
Table 142. Bayer AG Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Bayer AG Bile Duct Cancer Drug Product
Table 144. Bayer AG Recent Development
Table 145. Blueprint Medicines Corporation Corporation Information
Table 146. Blueprint Medicines Corporation Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Blueprint Medicines Corporation Description and Business Overview
Table 148. Blueprint Medicines Corporation Bile Duct Cancer Drug Product
Table 149. Blueprint Medicines Corporation Recent Development
Table 150. Boehringer Ingelheim GmbH Corporation Information
Table 151. Boehringer Ingelheim GmbH Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Boehringer Ingelheim GmbH Description and Business Overview
Table 153. Boehringer Ingelheim GmbH Bile Duct Cancer Drug Product
Table 154. Boehringer Ingelheim GmbH Recent Development
Table 155. Boston Biomedical, Inc. Corporation Information
Table 156. Boston Biomedical, Inc. Description and Business Overview
Table 157. Boston Biomedical, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Boston Biomedical, Inc. Bile Duct Cancer Drug Product
Table 159. Boston Biomedical, Inc. Recent Development
Table 160. Bristol-Myers Squibb Company Corporation Information
Table 161. Bristol-Myers Squibb Company Description and Business Overview
Table 162. Bristol-Myers Squibb Company Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Bristol-Myers Squibb Company Bile Duct Cancer Drug Product
Table 164. Bristol-Myers Squibb Company Recent Development
Table 165. Celgene Corporation Corporation Information
Table 166. Celgene Corporation Description and Business Overview
Table 167. Celgene Corporation Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Celgene Corporation Bile Duct Cancer Drug Product
Table 169. Celgene Corporation Recent Development
Table 170. CellAct Pharma GmbH Corporation Information
Table 171. CellAct Pharma GmbH Description and Business Overview
Table 172. CellAct Pharma GmbH Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. CellAct Pharma GmbH Bile Duct Cancer Drug Product
Table 174. CellAct Pharma GmbH Recent Development
Table 175. Cellceutix Corporation Corporation Information
Table 176. Cellceutix Corporation Description and Business Overview
Table 177. Cellceutix Corporation Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Cellceutix Corporation Bile Duct Cancer Drug Product
Table 179. Cellceutix Corporation Recent Development
Table 180. Cellular Biomedicine Group, Inc. Corporation Information
Table 181. Cellular Biomedicine Group, Inc. Description and Business Overview
Table 182. Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Product
Table 184. Cellular Biomedicine Group, Inc. Recent Development
Table 185. Concordia Healthcare Corp. Corporation Information
Table 186. Concordia Healthcare Corp. Description and Business Overview
Table 187. Concordia Healthcare Corp. Bile Duct Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Concordia Healthcare Corp. Bile Duct Cancer Drug Product
Table 189. Concordia Healthcare Corp. Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Bile Duct Cancer Drug Distributors List
Table 193. Bile Duct Cancer Drug Customers List
Table 194. Bile Duct Cancer Drug Market Trends
Table 195. Bile Duct Cancer Drug Market Drivers
Table 196. Bile Duct Cancer Drug Market Challenges
Table 197. Bile Duct Cancer Drug Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Bile Duct Cancer Drug Product Picture
Figure 2. Global Bile Duct Cancer Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Cabozantinib S-malate Product Picture
Figure 4. Elpamotide Product Picture
Figure 5. Exatecan Mesylate Product Picture
Figure 6. LY-2801653 Product Picture
Figure 7. NUC-1031 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Bile Duct Cancer Drug Sales Market Share by Application in 2021 & 2027
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Bile Duct Cancer Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bile Duct Cancer Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Bile Duct Cancer Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 16. Global Bile Duct Cancer Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 17. Global Bile Duct Cancer Drug Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Bile Duct Cancer Drug Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Bile Duct Cancer Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Bile Duct Cancer Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 21. Europe Bile Duct Cancer Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Bile Duct Cancer Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Bile Duct Cancer Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Bile Duct Cancer Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Bile Duct Cancer Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Bile Duct Cancer Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Bile Duct Cancer Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Bile Duct Cancer Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Bile Duct Cancer Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Bile Duct Cancer Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Bile Duct Cancer Drug Players Market Share by Revenue in Bile Duct Cancer Drug: 2016 & 2020
Figure 32. Bile Duct Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Bile Duct Cancer Drug Revenue Share by Type (2016-2021)
Figure 34. Global Bile Duct Cancer Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Bile Duct Cancer Drug Revenue Share by Application (2016-2021)
Figure 36. Global Bile Duct Cancer Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Bile Duct Cancer Drug Sales Market Share by Type in 2020
Figure 38. North America Bile Duct Cancer Drug Sales Market Share by Application in 2020
Figure 39. Europe Bile Duct Cancer Drug Sales Market Share by Type in 2020
Figure 40. Europe Bile Duct Cancer Drug Sales Market Share by Application in 2020
Figure 41. China Bile Duct Cancer Drug Sales Market Share by Type in 2020
Figure 42. China Bile Duct Cancer Drug Sales Market Share by Application in 2020
Figure 43. Japan Bile Duct Cancer Drug Sales Market Share by Type in 2020
Figure 44. Japan Bile Duct Cancer Drug Sales Market Share by Application in 2020
Figure 45. Southeast Asia Bile Duct Cancer Drug Sales Market Share by Type in 2020
Figure 46. Southeast Asia Bile Duct Cancer Drug Sales Market Share by Application in 2020
Figure 47. India Bile Duct Cancer Drug Sales Market Share by Type in 2020
Figure 48. India Bile Duct Cancer Drug Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Bile Duct Cancer Drug
Figure 51. Manufacturing Process Analysis of Bile Duct Cancer Drug
Figure 52. Bile Duct Cancer Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed